Your browser doesn't support javascript.
loading
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Lee, Dae Hyun; Kumar, Abhishek; Mohammed, Turab; Peres, Lauren C; Alsina, Melissa; Bachmeier, Christina; Blue, Brandon J; Brayer, Jason; Chandrasekhar, Sanjay; Grajales Cruz, Ariel; De Avila, Gabe; Elmariah, Hany; Faramand, Rawan; Freeman, Ciara; Jain, Michael; Khadka, Sushmita; Khimani, Farhad; Liu, Hien; Nishihori, Taiga; Oswald, Laura B; Castaneda Puglianini, Omar A; Shain, Kenneth H; Smith, Eric; Baz, Rachid C; Locke, Frederick L; Oliveira, Guilherme H; Alomar, Mohammed; Hansen, Doris K.
Affiliation
  • Lee DH; Division of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL.
  • Kumar A; Department of Cardio-Oncology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Mohammed T; Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL.
  • Peres LC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Alsina M; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Bachmeier C; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Blue BJ; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Brayer J; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Chandrasekhar S; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Grajales Cruz A; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • De Avila G; Division of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL.
  • Elmariah H; Department of Cardio-Oncology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Faramand R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Freeman C; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Jain M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Khadka S; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Khimani F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Liu H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Oswald LB; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Castaneda Puglianini OA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Shain KH; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Smith E; Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Baz RC; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Locke FL; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Oliveira GH; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Alomar M; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL.
Blood Adv ; 7(16): 4247-4257, 2023 08 22.
Article in En | MEDLINE | ID: mdl-37307173

Full text: 1 Database: MEDLINE Main subject: Neoplasms, Plasma Cell / Receptors, Chimeric Antigen / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Blood Adv Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Neoplasms, Plasma Cell / Receptors, Chimeric Antigen / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Blood Adv Year: 2023 Type: Article